Crispr People: The Science and Ethics of Editing Humans

Crispr People: The Science and Ethics of Editing Humans

By Henry T Greely

"Beginning with the amazing tale of the Chinese "CRISPR Babies," Greely tells the complex story of human germline editing, covering the science, ethics, law, and politics"--

READ FULL DESCRIPTION

Quantity Price Discount
List Price $27.95  
1 - 24 $23.76 15%
25 - 99 $17.33 38%
100 - 249 $16.77 40%
250 - 499 $16.21 42%
500 + $15.93 43%

Quick Quote

Lorem ipsum dolor sit amet, consectetur adipisicing elit

Non-returnable discount pricing

$27.95


Book Information

Publisher: MIT Press
Publish Date: 02/16/2021
Pages: 400
ISBN-13: 9780262044431
ISBN-10: 0262044439
Language: English

What We're Saying

Full Description

What does the birth of babies whose embryos had gone through genome editing mean--for science and for all of us? In November 2018, the world was shocked to learn that two babies had been born in China with DNA edited while they were embryos--as dramatic a development in genetics as the 1996 cloning of Dolly the sheep. In this book, Hank Greely, a leading authority on law and genetics, tells the fascinating story of this human experiment and its consequences. Greely explains what Chinese scientist He Jiankui did, how he did it, and how the public and other scientists learned about and reacted to this unprecedented genetic intervention. The two babies, nonidentical twin girls, were the first "CRISPR'd" people ever born (CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats, is a powerful gene-editing method). Greely not only describes He's experiment and its public rollout (aided by a public relations adviser) but also considers, in a balanced and thoughtful way, the lessons to be drawn both from these CRISPR'd babies and, more broadly, from this kind of human DNA editing--"germline editing" that can be passed on from one generation to the next. Greely doesn't mince words, describing He's experiment as grossly reckless, irresponsible, immoral, and illegal. Although he sees no inherent or unmanageable barriers to human germline editing, he also sees very few good uses for it--other, less risky, technologies can achieve the same benefits. We should consider the implications carefully before we proceed.

About the Author

Henry T. Greely is Professor of Law, Professor by Courtesy of Genetics, and Director of the Stanford Center for Law and the Biosciences at Stanford University, where he also chairs the Steering Committee of the Stanford University Center for Biomedical Ethics and directs the Stanford Program in Neur

Learn More

We have updated our privacy policy. Click here to read our full policy.